500 patients67,039 observations150 daysLIVE

Patient P-03081

Synthetic patientONX-7 · Day 143 · 55–64 · F · baseline S10Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Deteriorating
GI state
Stable
Inflammatory state
Stable
Nutritional resilience
Unstable
Discontinuation risk
58%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S10
  2. Day 55 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 71 GI-04 recommendedGI Support Protocol GI-04
  4. Day 72 Patient acceptedStarted GI-04 in the companion
  5. Day 80 GI symptom burden −21% vs expectedGI Support Protocol GI-04
  6. Day 86 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 55.

Primary contributors, last 14 days
  • Nutritional resilience-5
  • Treatment adherence+5
  • Toxicity+5
  • GI instability-2
  • Inflammatory activity-2

What helped?

  • GI Support Protocol GI-04Day 71
    Result: symptom burden −21%
LIFE OS recommendation
Supportive Compound SC-12
73%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 88% showed improvement
  • median effect visible after 6 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level
Daily log
3.4/10
improving · +0.2 vs previous 14 d
Stress level
Daily log
7.2/10
improving · -0.4 vs previous 14 d
Pessimism score
Daily log
5.7/10
stable · -0.1 vs previous 14 d
Sleep quality
Wearable
26.7/100
worsening · -1.7 vs previous 14 d
Libido
Daily log
2.2/10
worsening · -0.2 vs previous 14 d
HRV
Wearable
16.9 ms
stable · -0.3 vs previous 14 d
Toxicity
Blood
53.6/100
worsening · +3.4 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 38 from the failing basin, 51 from restoration.

Would help
  • ME-01 Monitoring Escalation
    100% improved among 11 similar · onset 3 d · confidence 70%
  • SC-12 Supportive Compound
    89% improved among 9 similar · onset 6 d · confidence 70%
  • NP-02 Dietary Support Protocol
    57% improved among 14 similar · onset 10 d · confidence 70%
  • More protein
    GI -3.5 next day on high-intake days · n 21
Would not help
  • AD-05 Adherence Support
    only 20% improved among 10 similar
  • Keep fat low
    GI +3.8 next day on high-intake days · n 20
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +3.8detractor · 95%
  • Protein
    -3.5supporter · 95%
  • Caffeine
    -0.7no signal · 21%
  • Histamine load
    -0.3no signal · 15%
  • Alcohol
    +0.3no signal · 15%
  • Lactose
    -0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 80
    • MicrobiomeButyrate capacity 27/100
    • MicrobiomeF. prausnitzii depleted
    • Daily logFibre intake low in recent food logs
  • Inflammatory signalling 65
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • BloodInflammatory load index 50
    • WearableHRV 17 ms, trending down
  • Mucosal barrier integrity 50
    • MicrobiomeAkkermansia low → thinner mucus layer
    • Daily logGI symptom score 53 and rising
  • Drug metabolism and exposure 20
    • BloodToxicity index 54
  • Autonomic recovery 20
    • Wearable2,307 steps/day
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 1.8 · butyrate capacity 27/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
18 ms
Sleep
6.7 h
Steps
2,098
Resting HR
65 bpm
Daily log: GI score 53, nutritional resilience 40, adherence 53.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0314218%S1584
P-0318718%S12AD-05no change80
P-0306618%S1778
P-0326418%S0876
P-0319518%S1376
P-0318119%S0375
P-0313418%S0975
P-0311321%S08NP-02no change73
P-0302319%S1673
P-0326618%S0573
P-0341220%S1472
P-0331519%S0872